Fintel reports that on October 10, 2025, Wolfe Research downgraded their outlook for Akero Therapeutics (NasdaqGS:AKRO) from Outperform to Peer Perform. Analyst Price Forecast Suggests 40.09% Upside ...

智通财经APP获悉，丹麦制药巨头诺和诺德(NVO.US)周四宣布已达成最终协议，将收购美国生物制药公司Akero Therapeutics(AKRO.US)，交易总价最高达52亿美元。根据协议条款，诺和诺德将以每股54美元、总价47亿美元现金收购Akero，并附带每股6美元不可转让的“或有价值权 ...

Alina Bradford has been writing how-tos, tech articles and more for almost two decades. She currently writes for CNET's Smart Home Section, MTVNews' tech section and for Live Science's reference ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Akero Therapeutics, Inc. (AKRO) one of those stocks right now ...

I oversee all our coverage of lifestyle topics, which include cleaning, organizing, wellness, entertaining, real estate, travel, and more. I’m based in Honolulu, Hawaii. Apartment Therapy’s ...

Contrary to what you may believe, a junk drawer is not meant to be a catch-all for life’s throwaways. That would be your trash can. Still, many people treat their junk drawer as a pre-garbage can ...

If you've ever looked up a guide to troubleshoot the most common Android problems, whether here on SlashGear or elsewhere on the web, you've likely been told to go to your device's app drawer. And if ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Akero Therapeutics, Inc. (AKRO) one of those stocks right now? By taking a look ...